Stem Cell and Exosome Therapy in Pulmonary Hypertension
- Authors
- Oh, Seyeon; Jung, Ji-Hye; Ahn, Kyung-Jin; Jang, Albert Youngwoo; Byun, Kyunghee; Yang, Phillip C.; Chung, Wook-Jin
- Issue Date
- Feb-2022
- Publisher
- 대한심장학회
- Keywords
- Stem cells; Exosomes; Pulmonary arterial hypertension; Right heart failure; N
- Citation
- Korean Circulation Journal, v.52, no.2, pp.110 - 122
- Journal Title
- Korean Circulation Journal
- Volume
- 52
- Number
- 2
- Start Page
- 110
- End Page
- 122
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/83584
- DOI
- 10.4070/kcj.2021.0191
- ISSN
- 1738-5520
- Abstract
- Pulmonary hypertension is a rare and progressive illness with a devastating prognosis. Promising research efforts have advanced the understanding and recognition of the pathobiology of pulmonary hypertension. Despite remarkable achievements in terms of improving the survival rate, reducing disease progression, and enhancing quality of life, pulmonary arterial hypertension (PAH) is not completely curable. Therefore, an effective treatment strategy is still needed. Recently, many studies of the underlying molecular mechanisms and technological developments have led to new approaches and paradigms for PAH treatment. Management based on stem cells and related paracrine effects, epigenetic drugs and gene therapies has yielded prospective results for PAH treatment in preclinical research. Further trials are ongoing to optimize these important insights into clinical circumstances.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
- 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/83584)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.